![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25821-25826, September 3, 1999
From the Department of Immunology and § Laboratory of
Molecular Pathogenesis, c-Src kinase was activated when either murine
NIH3T3 fibroblast cells or immunoprecipitated c-Src proteins were
treated with nitric oxide generator,
S-nitroso-N-acetyl penicillamine (SNAP) or
sodium nitroprusside. Nitric oxide (NO) scavenger hemoglobin and
N2O3 scavenger homocysteine abolished the
SNAP-mediated c-Src kinase activation. Phosphoamino acid analysis and
peptide mapping of in vitro labeled phospho-c-Src proteins
revealed that SNAP promoted the autophosphorylation at tyrosine, which
preferentially took place at Tyr-416. Peptide mapping of in
vivo labeled c-Src kinase excluded the involvement of
phospho-Tyr-527 dephosphorylation in the SNAP-mediated activation
mechanism. Correspondingly, protein-tyrosine phosphatase inhibitor
Na3VO4 did not abolish the SNAP-mediated activation of Src kinase, and the constitutively activated v-Src kinase
was also further up-regulated in activity by SNAP. SNAP, however,
failed to up-regulate the kinase activity of Phe-416 mutant v-Src.
2-Mercaptoethanol or dithiothreitol, which should disrupt
N2O3-mediated S-nitrosylation and
subsequent formation of the S-S bond, abolished the up-regulated
catalytic activity, and the activity was regained after re-exposing the
enzyme to SNAP. Exposure of Src kinase to SNAP promoted both
autophosphorylation and S-S bond-mediated aggregation of the kinase
molecules, demonstrating a linkage between the two events. These
results suggest that the NO/N2O3-provoked
S-nitrosylation/S-S bond formation destabilizes the Src
structure for Tyr-416 autophosphorylation-associated activation bypassing the Tyr-527-linked regulation.
p60c-src
(c-Src),1 a nonreceptor
protein-tyrosine kinase, is distributed widely in various cell types
and is potentially involved in the signal delivery for controlling
cellular growth and function (1, 2). In the resting fibroblasts, the
activity of c-Src kinase is tightly controlled by phosphorylation, and
the enzyme is found in an inactivated state in which the
carboxyl-terminal tyrosine 527 (Tyr-527) is phosphorylated to high
stoichiometry (3-5). The Tyr-527 phosphorylation is done by Csk,
another non-receptor type protein-tyrosine kinase (6, 7), and
dephosphorylation by phosphotyrosine phosphatase, which causes the
activation of c-Src kinase (2, 3). On the other hand, v-Src kinase,
which lacks a tail sequence containing Tyr-527, is not regulated by the
phosphorylation. This is why uncontrolled and constitutively activated
v-Src kinase plays a major role for unlimited cell growth (1-4).
Recently, tertiary structures of c-Src kinase and related molecules
were defined (8-10), and dephosphorylation of phospho-Tyr-527 or
binding of viral Nef protein with the SH3 domain has been suggested to
destabilize the whole kinase structure for activation. It is still an
open question whether some other chemical events could also destabilize
the structure of the Src kinase for activation.
Nitric oxide (NO), which is synthesized enzymatically from
L-arginine and molecular oxygen by nitric-oxide synthases
(11) or NO-generating chemicals have been shown to affect a number of
biological systems regulating various physiological and biochemical functions (12). Some of these include reduction of protein kinase C
activity (13) and activation of p21ras (14). Lander et
al. (15) report that treatment of lymphoma cells with
NO-generating agents increased the catalytic activity of p56lck
kinase, possibly through potentiating the phosphotyrosine phosphatase activity. The present study, to our knowledge, provides for the first
time evidences that NO released from these chemicals activates Src
kinase through a Tyr-527-independent and Tyr-416-linked mechanism, which involves S-nitrosylation/S-S bond-mediated
modification of Src molecules.
Cells and Chemicals--
The murine NIH3T3 fibroblast cell line
overexpressing c-Src kinase was kindly provided by Dr. D. Shalloway of
Pennsylvania State University. v-Src-transformed NIH3T3 cells were from
our own stock. The cell lines were cultured in plastic plates with Dulbecco's modified Eagle's medium supplemented with 10% fetal calf
serum at 37 °C in a 5% CO2, 95% air incubator. After
becoming confluent, cells were collected with 0.25% trypsin, 0.01%
EDTA in phosphate-buffered saline and were split into 60-mm plastic plates with Dulbecco's modified Eagle's medium containing 10% fetal
calf serum for a further 20-24-h incubation. The cells were then
rinsed with fresh modified Eagle's medium twice and incubated in
modified Eagle's medium at 37 °C for 1 h before use.
S-Nitroso-N-acetyl penicillamine (SNAP) was
purchased from Research Biochemicals Int. (Natick, MA), and sodium
nitroprusside (SNP), hemoglobin, and DL-homocysteine were
from Sigma.
Electrophoresis and Immunoblotting--
SDS-PAGE and immunoblots
were performed as described elsewhere (16). Briefly, proteins obtained
from lysed cells or immunoprecipitates (see below) were resolved on
SDS-10% polyacrylamide gels and were then transferred to a
polyvinylidene difluoride membrane. The membrane was incubated with
anti-phosphotyrosine polyclonal antibody (Transduction Lab., Lexington,
KY) or anti-Src monoclonal antibody (mAb327, donated by Dr. J. S. Brugge, State University of New York; Ref. 17) overnight at 4 °C and
then with the appropriate second antibody for 2 h at room
temperature. The proteins were visualized by Western blot
Chemiluminescence Reagent (NEN Life Science Products) as directed by
the manufacturer. The molecular sizes of the developed proteins were
estimated by comparison with prestained protein markers (New England
Biolabs, Beverly, MA).
Immunoprecipitation and in Vitro Kinase Assay--
Cells were
lysed with 1.0 ml of ice-cold lysis buffer (10 ml Tris-HCl, pH 8.0, 1%
Triton X-100, 150 mM NaCl, 1 mM EDTA, 0.5 mM Na3VO4, and 1 mM
phenylmethylsulfonyl fluoride). The lysate was centrifuged at
15,000 × g for 30 min at 4 °C, and anti-Src monoclonal antibody (mAb327) was added to the supernatant. The immunoprecipitates were collected by incubating with protein
A-Sepharose beads (Pierce) that had been conjugated with rabbit
anti-mouse IgG antibody (MBL, Nagoya, Japan). The beads bearing the
immunoprecipitates were washed three times with cold lysis buffer and
used for either immunoblot or in vitro kinase assay.
In vitro kinase assay was done as described previously (18).
Briefly, the immunoprecipitated Src proteins were washed 3 times with
kinase buffer (10 mM Tris-HCl, pH 7.4, 5 mM
MgCl2), suspended in the same buffer with 1.5 µg of
acid-denatured enolase (Sigma) as an exogenous substrate, and
radiolabeled [ Phosphoamino Acid Analysis--
32P-Labeled Src
protein bands were cut from the dried gel and rehydrated with 50 mM NH4HCO3. After rehydration, gel
slices were cut into smaller pieces and incubated at 37 °C overnight
with the addition of 50 µg/ml proteinase K. After centrifugation the supernatant was freeze-dried, dissolved in 6 N HCl, and
incubated at 85 °C for 1 h. The HCl was removed completely by
repeated freeze-drying. The hydrolysates thus obtained were mixed with
a mixture of marker amino acids containing phosphoserine,
phosphothreonine, and phosphotyrosine at a concentration of 1 mg/ml
each. Samples were then analyzed in two dimensions on cellulose-coated
glass plates (20 × 20 cm, Merck) by electrophoresis at pH 1.9 in
the first dimension and pH 3.5 in the second dimension as described by
Hunter and Sefton (19). After the second dimensional electrophoresis,
plates were dried and marker phosphoamino acids were detected by
staining with ninhydrin, and the labeled phosphoamino acids were
detected by autoradiography.
In Vivo Radiolabeling and Phosphopeptide Mapping of Src
Proteins--
NIH3T3 cells were labeled in vivo with
phosphorus-32 (H3PO4, 10 mCi/ml; NEN Life
Science Products) in phosphorus-free medium with 2% fetal calf serum
at a final concentration of 1 mCi/ml for 8 h as described
previously (7). Phosphorus-32-containing medium was discarded, and
cells were washed three times with modified Eagle's medium. The cells
were then lysed, and Src proteins were immunoprecipitated followed by
analysis on 10% SDS-polyacrylamide gels. The in vivo and
in vitro labeled Src proteins were excised from the dried
gel and digested with 50 mg/ml cyanogen bromide (CNBr, Sigma) in 70%
formic acid at room temperature for 1 h. Products were lyophilized
four or five times with 1 ml of distilled water until the pH became
neutral. The cleaved peptides were subjected to electrophoresis on a
24% acrylamide, 0.054% bisacrylamide gel (20, 21). Gels were dried
and exposed to x-ray film as described above.
Construction of Phe-416 Mutant v-Src--
A cDNA clone
containing the entire coding sequence of v-Src gene, obtained from
Schimidt-Ruppin strain of Rous sarcoma virus, was inserted between
BamHI and EcoRI sites of pBabe puro. Mutation for
tyrosine 416 to phenylalanine was introduced by polymerase chain
reaction (22, 23). In brief, primers containing the mutation was
synthesized and used for amplification of v-Src sequences. The
corresponding sequence of the v-Src gene was replaced with the mutated
fragment. The mutated fragment was then sequenced to confirm that
proper mutation was introduced.
NO Generator SNAP or SNP Activates c-Src Kinase--
When NIH3T3
cells overexpressing c-Src were incubated with 100-1000
µM SNAP or SNP, a number of cellular proteins were
phosphorylated at the tyrosine residue (Fig.
1A), and the c-Src kinase
activity was elevated compared with that in untreated (Nil)
cells (Fig. 1B). The increase in catalytic activity of the
kinase was shown for both autophosphorylation and phosphorylation of
enolase, which was used as an exogenous substrate.
We next tested the direct effect of SNAP on the kinase activity of
c-Src protein that had been isolated by immunoprecipitation from
lysates of NIH3T3 cells. The results are shown in Fig. 1C. Compared with no SNAP addition control (Nil), 5 and 50 µM SNAP definitely promoted the c-Src kinase activity as
shown by elevated autophosphorylation and phosphorylation of enolase.
As low concentration as 0.5 µM SNAP was also minimally
effective, whereas its high concentration, e.g. 500 µM, did not elevate the kinase activity over the control
level (data not shown). A similar but less marked effect was observed
with another NO generator SNP (data not shown).
A question arose whether the SNAP-mediated in vitro c-Src
kinase activation was actually mediated by NO released from SNAP or its
oxidized derivative N2O3, which may be in
equilibrium with NO (24). We showed that the SNAP-mediated c-Src kinase
activation was prevented both by NO scavenger hemoglobin (25, 26) and by N2O3 scavenger homocysteine (27) (Fig.
1D). This result supported the view that NO, or more
specifically, its oxidized derivative N2O3 was
the ultimate effector. Hemoglobin treatment caused even lower
phosphorylation of c-Src and enolase than the basal control (Nil).
The concentration of SNAP needed for activation of Src kinase in cells
(100-1000 µM; Fig. 1B) was much higher than
that for activation of the isolated enzyme (5-50 µM;
Fig. 1, C and D). Therefore, we tested whether
the high concentration of SNAP-induced increase in enzyme activity in
cells was really mediated by NO released from SNAP. As shown in Fig.
1E, NO scavenger hemoglobin completely inhibited the
SNAP-induced activation of Src kinase. There might also be a
possibility that the increase in Src kinase activity of the cells
treated with SNAP (See Fig. 1B) was due to the NO action on
Src molecules after cell lysis. To verify this we lysed the cells after
stimulating with SNAP in the presence of hemoglobin to scavenge the
possible action of NO after cell lysis. This treatment did not inhibit
the in vivo SNAP effect to promote the enzyme activity (Fig.
1E), excluding the above mentioned possibility.
Phosphoamino Acid and Phosphopeptide Mappings of in Vitro
Radiolabeled c-Src Proteins--
We examined whether the promotion of
c-Src kinase autophosphorylation by SNAP was at tyrosine residues. We
performed phosphoamino acid analysis of c-Src kinase that had been
excised from the dried gel after in vitro kinase assay. As
shown in Fig. 2A,
phosphorylation was only demonstrated at tyrosine but not at serine or
threonine, and the phosphorylation at tyrosine was preferentially
promoted by SNAP. This observation also indicated that the mechanism of the Src kinase activation mediated by SNAP does not involve an increase
in phosphorylation at serine or threonine residues.
We next performed the CNBr cleavage mapping of in vitro
activated autophosphorylated c-Src kinase to define whether the
elevated tyrosine phosphorylation was linked to phosphorylation at
Tyr-416 or Tyr-527. The result, as shown in Fig. 2B,
indicated that only a 10-kDa peptide that should contain Tyr-416 (20)
had been labeled with 32P, and SNAP treatment
preferentially increased this labeling. From this result it is evident
that SNAP activates the Src kinase in vitro linked to
selective promotion of autophosphorylation at Tyr-416.
Phosphopeptide Mapping of in Vivo Radiolabeled c-Src
Proteins--
c-Src kinase remains inactivated in the resting cells
due to phosphorylation of its carboxyl-terminal tyrosine 527 (3-5), and the enzyme becomes activated when phospho-Tyr-527 is
dephosphorylated (2, 3). We then performed experiments to test whether
phospho-Tyr-527 dephosphorylation would be involved in the mechanism of
SNAP-mediated in vivo activation of Src kinase as shown in
Fig. 1B. Cells were labeled with 32P in the
presence or absence of SNAP followed by immunoprecipitation and
SDS-PAGE. CNBr cleavage mapping was done with the
32P-labeled phosphorylated Src proteins that had been
excised from the gel of SDS-PAGE. As shown in Fig.
3, in vivo labeling occurred mainly on 4- and 31-kDa peptides that contain Tyr-527 and Ser-17, respectively (7, 20). SNAP treatment did not reduce the overall labeling of the 4-kDa peptide, suggesting that dephosphorylation of
phospho-Tyr-527 is not involved in the SNAP-mediated in vivo Src kinase activation. Interestingly, an additional labeling developed on 10-kDa peptide containing Tyr-416 upon treatment with SNAP. This
result may suggest that SNAP-mediated in vivo activation of
Src kinase also involves Tyr-416 phosphorylation.
SNAP-mediated in Vitro Src Kinase Activation Is Phospho-Tyr-527
Dephosphorylation-independent--
There is a possibility that the
potentially co-immunoprecipitated phosphotyrosine phosphatase, which
dephosphorylates phospho-Tyr-527, could be involved in the mechanism of
SNAP-mediated in vitro c-Src kinase activation. This is,
however, not very likely, because c-Src proteins were prepared for
in vitro kinase assay from the cell lysates in the lysis
buffer containing Na3VO4, a potent
phosphotyrosine phosphatase inhibitor. To further rule out this
possibility we treated the immunoprecipitated c-Src protein again with
Na3VO4 immediately before in vitro
kinase assay. This treatment did not change the background levels of
autophosphorylation and phosphorylation of enolase in the kinase assay
without SNAP (data not shown) and barely reduced the ability of SNAP to
activate Src kinase as shown in Fig.
4A. To further verify the
influence of phospho-Tyr-527 dephosphorylation for the SNAP-mediated
in vitro Src activation as a potential initiator, we tested
the effect of SNAP on the kinase activity of v-Src, which does not
contain the Tyr-527 residue. The result is shown in Fig. 4B.
To our surprise, v-Src kinase, which is constitutively activated
(compare basal control levels for c-Src and v-Src), was further
up-regulated in activity by SNAP (right panel). Moreover,
the extent of SNAP-mediated increase in v-Src kinase activity was not
less than that of c-Src kinase activity (left panel). These
results suggested that the dephosphorylation of phospho-Tyr-527 is not
a prerequisite for the Src kinase activation mediated by SNAP.
SNAP-mediated in Vitro Src Kinase Activation Is
Tyr-416-linked--
To examine whether Tyr-416 autophosphorylation is
the major event in SNAP-mediated in vitro activation of Src
kinase, we prepared v-Src with a mutation at tyrosine 416, replacing
with phenylalanine (Phe-416 mutant v-Src), and treated the mutated
enzyme with SNAP for in vitro kinase assay. The background
enzyme activity of the Phe-416 mutant v-Src to phosphorylate substrate
was lower than that of the wild type v-Src. Unlike the wild type v-Src,
the mutated enzyme was not up-regulated for the kinase activity to
phosphorylate substrate after the addition of SNAP (Fig.
5). This result strongly suggests that
Tyr-416 autophosphorylation is crucially involved in both basic Src
kinase activity and the SNAP-mediated promotion of the enzyme
activity.
SNAP-mediated Src Kinase Activation Results from a Sulfhydryl (SH)
Group Modification-mediated Reversible Mechanism--
The possible
role of SH group(s) modification in the mechanism of SNAP-mediated Src
kinase activation was then investigated. As expected from the earlier
reports (28-30) on chemical properties of NO and related chemical
compounds, we thought that NO released from SNAP or its oxidized
derivative N2O3 would react with thiol group(s)
of Src molecules to form protein-S-NO, which might eventually form
disulfides (S-S) with vicinal thiols by oxidation-reduction processes.
This change might underlie the mechanism of SNAP-induced Src kinase
activation. If this is the case, disruption of S-S bond(s) originally
formed by NO/N2O3 through
S-nitrosylation would abolish the SNAP-mediated increase in
the kinase activity. As shown in Figs.
6A (top) and
6B, SNAP-activated c-Src kinase (lane 2) lost its
high catalytic activity when treated with reducing agents such as 2-ME
and dithiothreitol (lane 3), which should interrupt the
NO/N2O3-mediated SH group modification forming
S-S bond. It is noted that the treatment of the kinase with 2-ME also diminished the spontaneous increase in the catalytic activity of the
kinase in vitro (compare lane 3 and lane
5 with lane 1 as control in Fig. 6A).
Surprisingly, however, by re-exposing the 2-ME-treated kinase after
washing to SNAP, the catalytic activity of the enzyme was
re-established (lane 4). During washing, after treating with
2-ME of the Src kinase, some of the proteins might have been lost. To
verify this possibility we performed an immunoblot experiment using
anti-Src antibody with individual samples. As shown in Fig.
6A (bottom), however, the amount of Src protein remained basically the same among the samples. These results suggested that the Src kinase was subjected to a reversible SH group modification for either activation or inactivation. A question arises here whether
some oxidants would show similar effects or not. To verify this point,
we added hydrogen peroxide to the isolated Src kinase for analyzing
activity of the enzyme. As shown in Fig. 6C, hydrogen peroxide also activated Src kinase in a
concentration-dependent manner. This result suggested that
a redox mechanism possibly following S-nitrosylation with
N2O3 for S-S bond formation would play an
important role in the chemical pathway of Src kinase activation.
SNAP-mediated Src Kinase Activation Accompanies Promotion of S-S
Bond-mediated Aggregation of the Kinase Molecules--
We next
conducted an experiment to ask if the Src proteins are actually
subjected to modification due to S-S bond formation as a manifestation
of the NO/N2O3-provoked mechanism. After
incubation of c-Src proteins with or without SNAP together with
[ Here for the first time we report evidences of an
NO/N2O3-provoked redox-based chemical
reaction-mediated, Tyr-416 autophosphorylation-linked mechanism for Src
kinase activation, which bypasses the known phospho-Tyr-527
dephosphorylation- (2, 3) or amino-terminal serine/threonine
phosphorylation- (31, 32) linked control. This evidence includes 1)
activation of c-Src kinase either in vivo (in cells) or
in vitro by treatment with NO-releasing SNAP or SNP (Fig. 1,
B and C) and inhibition by treatment with
NO-scavenging hemoglobin and by N2O3-scavenging
homocysteine (Fig. 1D); 2) selective promotion by SNAP of
phosphorylation at Tyr-416 of the Src kinase (Fig. 2); 3) no
dephosphorylation of Tyr-527 after in vivo treatment of
cells with SNAP (Fig. 3); 4) failure in prevention of the SNAP-mediated Src kinase activation with Na3VO4 as a
phosphotyrosine phosphatase inhibitor (Fig. 4A) and further
activation by SNAP of constitutively activated Tyr-527-defective v-Src
kinase (Fig. 4B); 5) failure in promotion by SNAP of the
kinase activity of Phe-416 mutant v-Src (Fig. 5); 6) mutually
counteracting reversible controls of Src kinase activity by SNAP and
reducing agents such as 2-ME (Fig. 6A) and dithiothreitol
(Fig. 6B); 7) association of the SNAP-mediated Src kinase
activation with promotion of S-S bond-mediated aggregation of the Src
molecules (Fig. 7).
The effective concentration of SNAP that increased the catalytic
activity of Src kinase was 100-1000 µM for cells (Fig.
1B, Fig. 3) and 5-50 µM for isolated Src
proteins (Fig. 1C and others). We showed that activation of
Src kinase by exposing the cells to 1000 µM SNAP (Fig.
1E) and by exposing isolated Src proteins to 50 µM SNAP (Fig. 1C) was inhibited by NO
scavenger hemoglobin. Activation of Src kinase by the latter was also
prevented by N2O3 scavenger homocysteine. These
results proved the involvement of NO and N2O3,
a closely related oxidized derivative of NO, in the activation
mechanism of both Src kinase in cells and isolated Src proteins.
Earlier studies examined the release of NO from SNAP and SNP, showing
that millimolar concentrations of these NO donors release free NO at
concentrations in the physiological range (33-36) and demonstrated
that 50-1000 µM NO donors are needed for NO-mediated
regulation of activities of protein kinase C (13), matrix
metalloproteinase (37, 38), prostaglandin H synthase (34),
N-methyl-D-aspartate receptor-channel complex
(28), and iron-responsive element-binding protein (39). In our
experimental system only a small portion of NO released from SNAP that
was added to the culture of cells probably entered the cell to affect the intracellular Src kinase, and low concentrations (0.5-5
µM) of SNAP were shown to be effective in activating
isolated Src kinase. Taken together, we consider that the effective
concentration of NO released from SNAP in the present study can be
physiologically relevant.
It has been reported earlier that NO/N2O3 can
aid S-S bond formation (28-30) through reaction of protein-SH with
NO/N2O3 to generate protein-S-NO, which then
oxidizes with another protein SH (28). This
NO/N2O3-induced intermolecular S-S bond
formation must underlie the SNAP-mediated Src protein aggregation that
accompanied increased autophosphorylation, although
NO/N2O3 might also induce Src protein
modification by S-nitrosylation and subsequent
intramolecular S-S bond formation. There are nine cysteines in c-Src
and v-Src, some of which could be located in a position to be
potentially modifiable externally. Our data suggest that reaction of
NO/N2O3 with these cysteine residues
facilitates formation of the S-S bond between Src molecules, thereby
inducing their aggregation. The demonstrated aggregation of Src
proteins due to intermolecular S-S bonds might mimic intracellular
accumulation of those kinase proteins following ligand-mediated
cross-linkage of cell surface receptors with which the kinase proteins
should associate and that are thereby crucial for Src kinase activation.
Recently defined tertiary structures of the Src and Src family kinases
(8-10) demonstrate that associations between the tail phospho-Tyr-527
(in case of c-Src) and SH2 domain and between the SH3 domain and kinase
N-lobe domain connected by the SH2 kinase linker sequence stabilize the
whole molecular structure of the kinase. This might put off the Tyr-416
(in the case of c-Src) phosphorylation-linked local switch in the
kinase domain (40). Dephosphorylation of phospho-Tyr-527 or binding of
the SH3 domain to some proline-rich sequences destabilizes the
structure to turn the local switch on for activation (8-10). Our
present results suggest an alternative pathway to destabilize the
kinase structure for activation through compelling individual Src
molecules to interact with each other by S-S bond. We do not, however,
exclude the possibility that some modification through
S-nitrosylation and redox reaction for intramolecular S-S
bond formation, which could occur in addition to intermolecular S-S
bond formation, might also be involved in the mechanism of Src kinase
activation. In any case, the newly demonstrated mechanism for Src
kinase activation did not work at all on the F416 mutant Src kinase. It
should therefore be that both, formerly known
Tyr-527-dependent and new Tyr-527-independent, mechanisms
put on the Tyr-416 phosphorylation-linked local switch for Src kinase activation.
c-Src in resting cells is basically in an inactive form (3-5) but is
partially activated spontaneously due to a yet unexplained reason when
isolated in vitro. Because treatment of the Src kinase with
reducing agents in vitro reversibly diminished the catalytic activity and because the environment inside the cell is normally reducing, the reducing condition may be physiologically crucial for
maintaining the kinase inactive in the resting cells. The demonstrated
SH group modification or redox-linked mechanism could work when cells
bearing Src kinase are put in the pathological microenvironment where
NO/N2O3 or superoxide is produced by
inflammatory cells in response to microorganism invasion. The same
mechanism might also play a role in the yet unidentified physiological
pathway of Src kinase activation, possibly providing the second
messenger of the putative cell surface receptor-mediated signal.
In short, the present results support the following summarized view.
The Src molecule is normally stabilized under reducing conditions
through intradomain association between SH2 and tail phospho-Tyr-527
and among SH3, SH2-kinase linker, and kinase N-lobe, which puts off the
local switch for the kinase activation. At least two different
mechanisms could destabilize the kinase structure to put on the Tyr-416
phosphorylation-linked local switch for increased catalytic activity.
One is through dissociation of the tail from SH2 by phospho-Tyr-527
dephosphorylation, and another is through SH group or redox
reaction-mediated modification of Src proteins including intermolecular
S-S bond formation for their aggregation.
We thank Dr. D. Shalloway and Dr. J. Brugge
for the gift of NIH3T3 overexpressing c-Src and mAb327 respectively. We
also thank Dr. S. Matsuda and Dr. Y. Nozaki for their help in in
vivo labeling of the cells and in measuring the density of protein
bands using the computer, respectively.
*
This work was supported in part by grant-in-aids for Center
of Excellence (COE) research from the Ministry of Education, Science, Sports, and Culture of Japan and by funds for comprehensive research on
aging and health from the Ministry of Health and Welfare of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviations used are:
c-Src, p60c-src;
SNAP, S-nitroso-N-acetyl
penicillamine;
2-ME, 2-mercaptoethanol;
SNP, sodium nitroprusside;
PAGE, polyacrylamide gel electrophoresis;
mAb, monoclonal
antibody.
Nitric Oxide Controls Src Kinase Activity through a
Sulfhydryl Group Modification-mediated Tyr-527-independent and
Tyr-416-linked Mechanism*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (370 kBq) (NEN Life Science
Products). This mixture was further added with or without chemicals as
modulators for kinase assay. The kinase reaction was carried out for 20 min at 30 °C and was stopped by adding 30 µl of 2× SDS sample
buffer with 2-mercaptoethanol (2-ME) unless otherwise noted. The
immunoprecipitates were then heated in a boiling water bath for 3 min,
and phosphoproteins were analyzed on 10% SDS-polyacrylamide gels. Gels
were dried and exposed to x-ray film at
80 °C for autoradiography.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
Nitric oxide-releasing SNAP and SNP activate
c-Src kinase in vivo and in vitro.
A and B, NIH3T3 cells that overexpress c-Src
kinase were incubated at 37 °C for 1 h with or without the
indicated concentrations of SNAP or SNP. They were then lysed with
sample buffer for immunoblotting with anti-phosphotyrosine antibody
(A) or with lysis buffer for immunoprecipitation and assay
of Src kinase activity (B and E). The amount of
Src protein in each lane of B determined by
immunoblotting with anti-Src antibody in parallel to the kinase assay
was invariable (not shown). C and D, NIH3T3 cells
were lysed, and c-Src proteins were immunoprecipitated for the in
vitro kinase assay. Indicated concentrations of SNAP with or
without 50 µM hemoglobin (Hb) or 1 mM homocysteine (H-Cys) (D) were
added to the reaction mixtures of immunoprecipitated c-Src proteins for
the kinase assay. E, cells were incubated with or without 1 mM SNAP as described in panel B. 2 mM hemoglobin was either added together with SNAP or added
during cell lysis after treatment with SNAP (the right-most
lane). The assay of Src kinase activity was done as
described above. Positions of molecular mass markers are shown on the
left, and those of the Src protein and enolase (E) are shown
on the right. A representative of three experiments with consistent
results is shown.

View larger version (31K):
[in a new window]
Fig. 2.
Determination of the site of
autophosphorylation in the SNAP-treated in vitro radiolabeled c-Src molecule. c-Src proteins isolated by
immunoprecipitation were labeled in vitro by incubating with
[
-32P]ATP without (Nil) or with 5 µM SNAP and were then subjected to SDS-PAGE. The bands
developed for labeled Src proteins were excised from the dried gel.
A, the isolated Src proteins were subjected to acid
hydrolysis. Phosphoamino acids of the hydrolysates were separated in
two dimensions; the first dimension was carried out from left to right,
and the second dimension was carried out from bottom to top. Positions
of phosphoserine, phosphothreonine, and phosphotyrosine are indicated
as pS, pT, and pY, respectively.
B, the isolated Src proteins were cleaved to completion with
CNBr. The resulting phosphopeptides were analyzed by 24% SDS-PAGE as
described in the text. The positions of the molecular mass markers are
shown on the left, and that of the 10-kDa phosphopeptide is shown on
the right.

View larger version (36K):
[in a new window]
Fig. 3.
Phosphopeptide mapping of in vivo radiolabeled c-Src proteins. NIH3T3 cells overexpressing
c-Src kinase were incubated at 37 °C for 8 h in the presence of
phosphorus-32. 1 mM SNAP was added to one group of the
cells at 20 min before the end of an 8-h incubation. The cells were
then lysed, and Src proteins were immunoprecipitated and analyzed by
SDS-PAGE. The bands for Src proteins were excised from the gel and
cleaved to completion with CNBr. The resulting phosphopeptides were
analyzed by 24% SDS-PAGE as described in the text. The positions of
molecular mass markers are shown on the left, and those of the 31-, 10-, and 4-kDa phosphopeptide are shown on the right. The ratios of
density of the 4-kDa peptide to the 31-kDa peptide determined by
densitometry for lanes 1 and 2 were 0.159 and
0.164, respectively.

View larger version (26K):
[in a new window]
Fig. 4.
SNAP-mediated activation of Src kinase is
independent of phosphotyrosine phosphatase/Tyr-527-linked control.
A, NIH3T3 cells were lysed, and c-Src proteins were
immunoprecipitated. Then 5 µM SNAP or 500 µM Na3VO4 followed by 5 µM SNAP at a 20-min interval was added to the reaction
mixture of immunoprecipitated Src proteins for the kinase assay.
Left lane, no addition (Nil), control.
B, NIH3T3 cells that overexpress c-Src (left
panel) or v-Src (right panel) were lysed, and c-Src and
v-Src proteins were immunoprecipitated and treated with 5-50
µM SNAP for the kinase assay. Positions of molecular mass
markers are shown on the left, and those of the Src protein and enolase
(E) are shown on the right. A representative of three
experiments with consistent results is shown.

View larger version (29K):
[in a new window]
Fig. 5.
SNAP does not activate Src kinase when
tyrosine 416 is replaced with phenylalanine. NIH3T3 cells
overexpressing v-Src kinase or Y416F-mutated v-Src kinase were lysed,
and Src proteins were immunoprecipitated for in vitro kinase
assay. 50 µM SNAP were added to the indicated reaction
mixtures of immunoprecipitated Src proteins for the kinase assay. The
positions of molecular mass markers are shown on the left, and those of
the Src protein and enolase (E) are shown on the right. A
representative of three experiments with consistent results is
shown.

View larger version (40K):
[in a new window]
Fig. 6.
Evidence of involvement of SH group
modification of the kinase molecule in the mechanism of SNAP-mediated
activation of Src kinase. A, top, the
immunoprecipitated c-Src proteins, suspended in kinase buffer, were
incubated without (lane 1) or with 5 µM of
SNAP (lanes 2, 3, and 4) or 5% 2-ME
(lane 5) at 30 °C for 15 min. Then 5% 2-ME was added to
the reaction mixtures of lanes 3 and 4 at 10 min
after the start of the incubation. These samples were washed twice with
kinase buffer, and 5 µM SNAP was added for the second
time to the sample of lane 4. All of the samples were then
incubated with [
-32P]ATP together with enolase for 20 min at 30 °C. The reaction was stopped by adding sample buffer
followed by analysis of the samples on 10% SDS-polyacrylamide gel.
A, bottom, the immunoprecipitated Src proteins
were treated the same as described above. After washing, sample buffer
was added to the immunoprecipitates, and the immunoprecipitated samples
were then resolved on 10% SDS-polyacrylamide gel and examined by
immunoblotting with anti-Src (mAb327) antibody. B and
C, the immunoprecipitated c-Src proteins, suspended in
kinase buffer, were incubated with or without 5 µM SNAP
or 5 µM SNAP plus 10 mM dithiothreitol
(DTT) (B) or indicated concentrations of SNAP or
hydrogen peroxide for 20 min at 30 °C (C), and the
in vitro kinase assay was then conducted in the presence of
[
-32P]ATP and enolase (E).
-32P]ATP for the kinase assay, the reaction was
stopped by adding sample buffer plus or minus 2-ME. As shown in Fig.
7, for both SNAP-untreated
(Nil) and -treated assays, considerable amounts of
autophosphorylated Src proteins were detected at the upper portion of
the separating gel under unreducing conditions (right panel), which were dissociated under reducing condition
(left panel). The ratio of aggregated to nonaggregated
autophosphorylated Src proteins from the SNAP-treated assay, determined
using appropriate computer software, was 1.61, which was higher than
0.94, the ratio of untreated control. This result evidenced the
involvement of the S-S bond-mediated modification of the kinase
molecules in the mechanism of the SNAP-induced kinase activation.

View larger version (33K):
[in a new window]
Fig. 7.
Linkage between SNAP-mediated activation and
aggregation of Src molecules. c-Src proteins isolated by
immunoprecipitation were incubated with or without 5 µM
SNAP (in duplicate) in kinase buffer at 30 °C for 20 min together
with [
-32P]ATP. The reaction was stopped by adding
2-ME (+) (left panel) and 2-ME (
) (right panel)
sample buffer, and the Src proteins were then subjected to SDS-PAGE.
Positions of molecular mass markers are shown on the left, and those of
the monomeric and aggregated Src proteins are shown on the right. A
representative of three experiments with consistent results is
shown.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Recipient of a fellowship from the Ministry of Health and Welfare
on Research for Health Science.
To whom correspondence should be addressed. Tel.:
81-52-744-2134; Fax: 81-52-744-2972; E-mail:
inakashi@tsuru.med.nagoya-u.ac.jp.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Cantley, L. C.,
Auger, K. R.,
Carpenter, C.,
Duckworth, B.,
Graziani, A.,
Kapeller, R.,
and Soltoff, S.
(1991)
Cell
64,
281-302[CrossRef][Medline]
[Order article via Infotrieve]
2.
Cooper, J. A.,
and Howell, B.
(1993)
Cell
73,
1051-1054[Medline]
[Order article via Infotrieve]
3.
Cooper, J. A.,
and MacAuley, A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4232-4236 4.
Kmiecik, T. E.,
and Shalloway, D.
(1987)
Cell
49,
65-73[CrossRef][Medline]
[Order article via Infotrieve]
5.
Piwnica-Worms, H.,
Saunders, K. B.,
Roberts, T.,
Smith, A. E.,
and Cheng, S. H.
(1987)
Cell
49,
75-82[CrossRef][Medline]
[Order article via Infotrieve]
6.
Nada, S.,
Okada, M.,
MacAuley, A.,
Cooper, J. A.,
and Nakagawa, H.
(1991)
Nature
351,
69-72[CrossRef][Medline]
[Order article via Infotrieve]
7.
Thomas, J. E.,
Soriano, P.,
and Brugge, J. S.
(1991)
Science
254,
568-571 8.
Xu, W.,
Harrison, S. C.,
and Eck, M. J.
(1997)
Nature
385,
595-602[CrossRef][Medline]
[Order article via Infotrieve]
9.
Sicheri, F.,
Moarefi, I.,
and Kuriyan, J.
(1997)
Nature
385,
602-609[CrossRef][Medline]
[Order article via Infotrieve]
10.
Moarefi, I.,
LaFevre-Bernt, M.,
Sicheri, F.,
Huse, M.,
Lee, C.,
Kuriyan, J.,
and Miller, W. T.
(1997)
Nature
385,
650-653[CrossRef][Medline]
[Order article via Infotrieve]
11.
Marletta, M. A.
(1994)
Cell
78,
927-930[CrossRef][Medline]
[Order article via Infotrieve]
12.
Nathan, C.,
and Xie, Q.
(1994)
Cell
78,
915-918[CrossRef][Medline]
[Order article via Infotrieve]
13.
Gopalakrisna, R.,
Chen, Z. H.,
and Gundimeda, U.
(1993)
J. Biol. Chem.
268,
27180-27185 14.
Lander, H. M.,
Milbank, A. J.,
Tauras, J. M.,
Hajjar, D. P.,
Hempstead, B. L.,
Schwartz, G. D.,
Kraemer, R. T.,
Mirza, U. A,
Chait, B. T.,
Burk, S. C.,
and Quilliam, L. A.
(1996)
Nature
381,
380-381[CrossRef][Medline]
[Order article via Infotrieve]
15.
Lander, H. M.,
Sehajpal, P.,
Levine, D. M.,
and Novogrodsky, A.
(1993)
J. Immunol.
150,
1509-1516[Abstract]
16.
Nakashima, I.,
Zhang, Y-H.,
Rahman, S. M. J.,
Yoshida, T.,
Isobe, K.,
Ding, L.,
Iwamoto, T.,
Hamaguchi, M.,
Ikezawa, H.,
and Taguchi, R.
(1991)
J. Immunol.
147,
1153-1162[Abstract]
17.
Lipsich, L. A.,
Lewis, A. J.,
and Brugge, J. S.
(1983)
J. Virol.
48,
352-360 18.
Hamaguchi, M.,
Xiao, H.,
Uehara, Y.,
Ohnishi, Y.,
and Nagai, Y.
(1993)
Oncogene
8,
559-564[Medline]
[Order article via Infotrieve]
19.
Hunter, T.,
and Sefton, B. M.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1311-1315 20.
Schuh, S. M.,
and Brugge, J. S.
(1988)
Mol. Cell. Biol.
8,
2465-2471 21.
Imamoto, A.,
and Soriano, P.
(1993)
Cell
73,
1117-1124[CrossRef][Medline]
[Order article via Infotrieve]
22.
Ito, W.,
Ishiguro, H.,
and Kurosawa, Y.
(1991)
Gene
102,
67-70[CrossRef][Medline]
[Order article via Infotrieve]
23.
Mikaelian, I.,
and Sergeant, A.
(1992)
Nucleic Acids Res.
20,
376 24.
Stamler, J. S.,
Singel, D. J.,
and Loscalzo, J.
(1992)
Science
258,
1898-1902 25.
Ignarro, L. J.,
Buga, G. M.,
Wood, K. S.,
Byrns, R. E.,
and Chaudhuri, G.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
89,
1031-1035 26.
Garg, U. C.,
and Hassid, A.
(1989)
J. Clin. Invest.
83,
1774-1777
27.
Groot, M. A. D.,
Testerman, T.,
Xu, Y.,
Stauffer, G.,
and Fang, F. C.
(1996)
Science
272,
414-416[Abstract]
28.
Lei, S. Z.,
Pan, Z.,
Aggarwal, S. K.,
Chen, H. V.,
Hartman, J.,
Sucher, N. J.,
and Lipton, S. A.
(1992)
Neuron
8,
1087-1099[CrossRef][Medline]
[Order article via Infotrieve]
29.
Lipton, S. A.,
Choi, Y. B.,
Pan, Z. H.,
Lei, S. Z,
Chen, S. H. V.,
Sucher, N. J.,
Loscalzo, J.,
Singel, D. J.,
and Stamler, J. S.
(1993)
Nature
364,
626-632[CrossRef][Medline]
[Order article via Infotrieve]
30.
Stamler, J. S.
(1994)
Cell
78,
931-936[CrossRef][Medline]
[Order article via Infotrieve]
31.
Chackalaparampil, I.,
and Shalloway, D.
(1988)
Cell
52,
801-810[CrossRef][Medline]
[Order article via Infotrieve]
32.
Shenoy, S.,
Choi, J. K.,
Bagrodia, S.,
Copeland, T. D.,
Maller, J. L.,
and Shalloway, D.
(1989)
Cell
57,
763-774[CrossRef][Medline]
[Order article via Infotrieve]
33.
Maccarrone, M.,
Corasaniti, M. T.,
Guerrieri, P.,
Nistico, G.,
and Finazzi Agro, A.
(1996)
Biochem. Biophys. Res. Commun.
219,
128-133[CrossRef][Medline]
[Order article via Infotrieve]
34.
Maccarrone, M.,
Putti, S.,
and Finazzi Agro, A.
(1997)
FEBS Lett.
410,
470-476[CrossRef][Medline]
[Order article via Infotrieve]
35.
Bauer, J. A.,
Booth, B. P.,
and Fung, H.-L.
(1995)
in
Advances in Pharmacology
(Ignarro, L.
, and Murad, F., eds), Vol. 34
, pp. 361-381, Academic Press, Inc., San Diego
36.
Matthews, J. R.,
Botting, C. H.,
Panico, M.,
Morris, H. R.,
and Hay, R. T.
(1996)
Nucleic Acids Res.
24,
2236-2242 37.
Trachtman, H.,
Futterweit, S.,
Garg, P.,
Reddy, K.,
and Singhal, P. C.
(1996)
Biochem. Biophys. Res. Commun.
218,
704-708[CrossRef][Medline]
[Order article via Infotrieve]
38.
Murrell, G. A.,
Jang, D.,
and Williams, R. J.
(1995)
Biochem. Biophys. Res. Commun.
206,
15-21[CrossRef][Medline]
[Order article via Infotrieve]
39.
Richardson, D. R.,
Neumannova, V.,
Nagy, E.,
and Ponka, P.
(1995)
Blood
86,
3211-3219 40.
Yamagushi, H.,
and Hendrickson, W. A.
(1996)
Nature
384,
484-498[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M.-C. Maa, M. Y. Chang, Y.-J. Chen, C.-H. Lin, C. J. Yu, Y. L. Yang, J. Li, P.-R. Chen, C.-H. Tang, H.-Y. Lei, et al. Requirement of Inducible Nitric-oxide Synthase in Lipopolysaccharide-mediated Src Induction and Macrophage Migration J. Biol. Chem., November 14, 2008; 283(46): 31408 - 31416. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Basu, L. Kole, M. Basu, K. Chakraborty, P. S. Mitra, and I. S. Owens The Major Chemical-detoxifying System of UDP-glucuronosyltransferases Requires Regulated Phosphorylation Supported by Protein Kinase C J. Biol. Chem., August 22, 2008; 283(34): 23048 - 23061. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Moiseeva, R. Heukers, and M. M. Manson EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells Carcinogenesis, February 1, 2007; 28(2): 435 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. He, J. Huang, C. F. Lagenaur, and E. Aizenman Methylisothiazolinone, A Neurotoxic Biocide, Disrupts the Association of Src Family Tyrosine Kinases with Focal Adhesion Kinase in Developing Cortical Neurons J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1320 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lindermayr, G. Saalbach, G. Bahnweg, and J. Durner Differential Inhibition of Arabidopsis Methionine Adenosyltransferases by Protein S-Nitrosylation J. Biol. Chem., February 17, 2006; 281(7): 4285 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Das and N. Maulik Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv., February 1, 2006; 6(1): 36 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhou, L. Liu, and D. Hu Involvement of BKCa {alpha} subunit tyrosine phosphorylation in vascular hyporesponsiveness of superior mesenteric artery following hemorrhagic shock in rats Cardiovasc Res, November 1, 2005; 68(2): 327 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Basu, S. Kubota, M. R. Meselhy, M. Ciotti, B. Chowdhury, M. Hartori, and I. S. Owens Gastrointestinally Distributed UDP-glucuronosyltransferase 1A10, Which Metabolizes Estrogens and Nonsteroidal Anti-inflammatory Drugs, Depends upon Phosphorylation J. Biol. Chem., July 2, 2004; 279(27): 28320 - 28329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Marshall, D. T. Hess, and J. S. Stamler S-nitrosylation: Physiological regulation of NF-{kappa}B PNAS, June 15, 2004; 101(24): 8841 - 8842. [Full Text] [PDF] |
||||